Preclinical testing of an Atr inhibitor demonstrates improved response to standard therapies for esophageal cancer

Preclinical testing of an Atr inhibitor demonstrates improved response to standard therapies for esophageal cancer

Bibliographic Details
Main Authors: Leszczynska, Katarzyna B., Dobrynin, Greg, Leslie, Rhea E., Ient, Jonathan, Boumelha, Adam J., Senra, Joana M., Hawkins, Maria A., Maughan, Tim, Mukherjee, Somnath, Hammond, Ester M.
Format: Online
Language:English
Published: Elsevier Scientific Publishers 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154234/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154234/

Similar Items